417
Views
14
CrossRef citations to date
0
Altmetric
Pharmacotherapy

Cost–utility analysis of once-daily versus twice-daily inhaled corticosteroid dosing for maintenance treatment of asthma in pediatric patients

, MD, Msc, , MD, MSc & , MD, PhD
Pages 538-545 | Received 16 Jul 2015, Accepted 31 Oct 2015, Published online: 19 Jan 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Carlos E. Rodriguez-Martinez & Monica P. Sossa-Briceño. (2022) Are we overcoming our inability to have pediatric patients properly use inhaled corticosteroids by inappropriately escalating their therapy?. Journal of Asthma 59:7, pages 1360-1371.
Read now
Sin Mei Khaw,Shu Chuen Li,Nurul Ain Mohd Tahir,. (2022) A systematic review of the cost-effectiveness of medicationadherence-enhancing intervention for asthma. Journal of Asthma 59:4, pages 697-711.
Read now
Bunchai Chongmelaxme, Nathorn Chaiyakunapruk & Piyameth Dilokthornsakul. (2019) Incorporating adherence in cost-effectiveness analyses of asthma: a systematic review. Journal of Medical Economics 22:6, pages 554-566.
Read now
Carlos E. Rodriguez-Martinez, Monica P. Sossa-Briceño & Jose A. Castro-Rodriguez. (2018) A cost-effectiveness threshold analysis of a multidisciplinary structured educational intervention in pediatric asthma. Journal of Asthma 55:5, pages 561-570.
Read now

Articles from other publishers (10)

Carlos E. Rodriguez-Martinez, Monica P. Sossa-Briceño & Manuel E. Soto-Martinez. (2023) The Use of Bacterial Lysate for the Prevention of Wheezing Episodes in Preschool Children: A Cost-Utility Analysis. The Journal of Allergy and Clinical Immunology: In Practice 11:1, pages 220-227.
Crossref
G. Jébrak, V. Houdouin, P. Terrioux, N. Lambert, B. Maitre & A.-M. Ruppert. (2022) Observance thérapeutique dans l’asthme : variation selon les classes d’âge. Comment l’améliorer ? Apport des nouvelles technologies. Revue des Maladies Respiratoires 39:5, pages 442-454.
Crossref
Carlos E. Rodriguez‐Martinez, Monica P. Sossa‐Briceño & Jose A. Castro‐Rodriguez. (2021) Cost‐utility of omalizumab for the treatment of uncontrolled moderate‐to‐severe persistent pediatric allergic asthma in a middle‐income country. Pediatric Pulmonology 56:9, pages 2987-2996.
Crossref
Elida Duenas‐Meza, Luis F. Giraldo‐Cadavid, Elizabeth Karpf, Felipe Afanador, Olga L. Angarita, Oscar Barón, Maria S. Medina, Angelica Pachón, Angelica Gonzalez, Jenny Jurado & Carlos A. Torres‐Duque. (2020) Cost‐utility analysis of an integrated care program for children with asthma in a medium‐income country. Pediatric Pulmonology 55:11, pages 3110-3118.
Crossref
J. Mark FitzGerald, Sofie Arnetorp, Caitlin Smare, Danny Gibson, Karen Coulton, Kirsty Hounsell, Sarowar Golam & Mohsen Sadatsafavi. (2020) The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK. Respiratory Medicine 171, pages 106079.
Crossref
Luca Adél Halmai, Aileen Rae Neilson & Mary Kilonzo. (2019) Economic evaluation of interventions for the treatment of asthma in children: A systematic review. Pediatric Allergy and Immunology 31:2, pages 150-157.
Crossref
Solmaz Ehteshami-Afshar, Zafar Zafari, Nima Hamidi, J. Mark FitzGerald, Larry Lynd & Mohsen Sadatsafavi. (2019) A Systematic Review of Decision-Analytic Models for Evaluating Cost-Effectiveness of Asthma Interventions. Value in Health 22:9, pages 1070-1082.
Crossref
Elham Hossny, Luis Caraballo, Thomas Casale, Yehia El-Gamal & Lanny Rosenwasser. (2017) Severe asthma and quality of life. World Allergy Organization Journal 10, pages 28.
Crossref
Elham Hossny, Nelson Rosario, Bee Wah Lee, Meenu Singh, Dalia El-Ghoneimy, Jian Yi SOH & Peter Le Souef. (2016) The use of inhaled corticosteroids in pediatric asthma: update. World Allergy Organization Journal 9, pages 26.
Crossref
Sarika Gupta & Shally Awasthi. (2016) Assessment of treatment pattern of childhood asthma reporting to outpatients’ facility of a tertiary care hospital in Lucknow, North India: A cross-sectional study. Clinical Epidemiology and Global Health 4, pages S6-S11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.